AU2022901165A0 - Anti-NPY-Y1 antibodies and uses thereof - Google Patents

Anti-NPY-Y1 antibodies and uses thereof

Info

Publication number
AU2022901165A0
AU2022901165A0 AU2022901165A AU2022901165A AU2022901165A0 AU 2022901165 A0 AU2022901165 A0 AU 2022901165A0 AU 2022901165 A AU2022901165 A AU 2022901165A AU 2022901165 A AU2022901165 A AU 2022901165A AU 2022901165 A0 AU2022901165 A0 AU 2022901165A0
Authority
AU
Australia
Prior art keywords
npy
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022901165A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welcome Receptor Antibodies Pty Ltd
Original Assignee
Welcome Receptor Antibodies Pty Ltd
Filing date
Publication date
Application filed by Welcome Receptor Antibodies Pty Ltd filed Critical Welcome Receptor Antibodies Pty Ltd
Publication of AU2022901165A0 publication Critical patent/AU2022901165A0/en
Pending legal-status Critical Current

Links

AU2022901165A 2022-05-04 Anti-NPY-Y1 antibodies and uses thereof Pending AU2022901165A0 (en)

Publications (1)

Publication Number Publication Date
AU2022901165A0 true AU2022901165A0 (en) 2022-05-19

Family

ID=

Similar Documents

Publication Publication Date Title
EP4010378A4 (en) Anti-ccr8 monoclonal antibodies and uses thereof
EP4151652A4 (en) Anti-cd73 antibody and use thereof
EP4039708A4 (en) Anti-cll1 antibody and application thereof
EP3999545A4 (en) Anti-cd73 antibody and application thereof
EP4139347A4 (en) Anti-cd3 antibodies and uses thereof
EP4095160A4 (en) Anti-st2 antibody and application thereof
EP4126938A4 (en) Antibodies binding siglec15 and uses thereof
EP4071172A4 (en) Anti-lilrb1 antibody and uses thereof
EP4159763A4 (en) Anti-cd73 antibody and use thereof
EP4234580A4 (en) Nkg2a-targeting antibody and use thereof
EP4001308A4 (en) Anti-tigit antibodies and application thereof
EP4095157A4 (en) Anti-angptl3 antibody and use thereof
AU2022242135A1 (en) Anti-tau antibodies and uses thereof
EP4132974A4 (en) Anti-cd98 antibodies and uses thereof
TWI799855B (en) NOVEL MONOCLONAL ANTIBODIES AGAINST SARS-CoV-2 AND USES THEREOF
AU2022298850A1 (en) Anti-ccr8 antibodies and uses thereof
EP4153313A4 (en) Anti-sars-cov-2 antibodies and uses thereof
EP4169950A4 (en) Anti-lilrb1 antibody and uses thereof
EP4274851A4 (en) Anti-gprc5d monoclonal antibodies and uses thereof
EP4079758A4 (en) Semg2 antibody and use thereof
AU2023901399A0 (en) Anti-SARS-CoV-2 antibodies and uses thereof
AU2023901335A0 (en) Anti-NPY-Y1 antibodies and uses thereof
AU2022901165A0 (en) Anti-NPY-Y1 antibodies and uses thereof
AU2023901400A0 (en) Anti-SARS-CoV-2 antibodies and uses thereof II
AU2023901403A0 (en) Anti-SARS-CoV-2 antibodies and uses thereof III